MARKET

ACON

ACON

Aclarion Inc
NASDAQ
7.30
+0.20
+2.82%
Opening 09:53 05/12 EDT
OPEN
7.31
PREV CLOSE
7.10
HIGH
7.31
LOW
7.30
VOLUME
4.67K
TURNOVER
--
52 WEEK HIGH
3,499.51
52 WEEK LOW
6.20
MARKET CAP
4.25M
P/E (TTM)
-0.0010
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACON last week (0505-0509)?
Weekly Report · 3h ago
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
Barchart · 7h ago
Weekly Report: what happened at ACON last week (0428-0502)?
Weekly Report · 05/05 10:21
Aclarion Expands CLARITY Trial with Advocate Aurora Research Institute to Improve Chronic Back Pain Diagnosis
Benzinga · 05/05 10:08
Aclarion Welcomes Advocate Health as CLARITY Trial Site
Barchart · 05/05 05:00
Aclarion announces agreement with the Spine Institute of Louisiana
TipRanks · 04/29 10:15
ACLARION ANNOUNCES COMMERCIAL AGREEMENT WITH SPINE INSTITUTE OF LOUISIANA
Reuters · 04/29 10:00
ACLARION INC - NOCISCAN NOW AVAILABLE IN LOUISIANA THROUGH SIL AGREEMENT
Reuters · 04/29 10:00
More
About ACON
More
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Recently
Symbol
Price
%Change

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.